Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.

Hlavna M, Raudenska M, Hudcova K, Gumulec J, Sztalmachova M, Tanhäuserova V, Babula P, Adam V, Eckschlager T, Kizek R, Masarik M.

Int J Oncol. 2012 Dec;41(6):2237-44. doi: 10.3892/ijo.2012.1655. Epub 2012 Oct 9.

PMID:
23064315
2.

Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining.

Masarik M, Gumulec J, Hlavna M, Sztalmachova M, Babula P, Raudenska M, Pavkova-Goldbergova M, Cernei N, Sochor J, Zitka O, Ruttkay-Nedecky B, Krizkova S, Adam V, Kizek R.

Integr Biol (Camb). 2012 Jun;4(6):672-84. doi: 10.1039/c2ib00157h. Epub 2012 May 16.

PMID:
22592803
3.

Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers.

Gumulec J, Masarik M, Krizkova S, Hlavna M, Babula P, Hrabec R, Rovny A, Masarikova M, Sochor J, Adam V, Eckschlager T, Kizek R.

Neoplasma. 2012;59(2):191-201.

PMID:
22248277
4.

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O.

Cancer Res. 2011 Mar 1;71(5):1956-67. doi: 10.1158/0008-5472.CAN-10-2421. Epub 2011 Feb 22.

5.

miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.

Zhang W, Edwards A, Fan W, Flemington EK, Zhang K.

PLoS One. 2012;7(6):e40130. doi: 10.1371/journal.pone.0040130. Epub 2012 Jun 29.

6.

The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells.

Ku JH, Seo SY, Kwak C, Kim HH.

Urol Oncol. 2012 Sep;30(5):562-8. doi: 10.1016/j.urolonc.2010.06.001. Epub 2010 Sep 6.

PMID:
20822926
7.

KRAS NF-κB is involved in the development of zinc resistance and reduced curability in prostate cancer.

Holubova M, Axmanova M, Gumulec J, Raudenska M, Sztalmachova M, Babula P, Adam V, Kizek R, Masarik M.

Metallomics. 2014 Jul;6(7):1240-53. doi: 10.1039/c4mt00065j.

PMID:
24927480
8.

Effect of zinc(II) ions on the expression of pro- and anti-apoptotic factors in high-grade prostate carcinoma cells.

Sztalmachova M, Hlavna M, Gumulec J, Holubova M, Babula P, Balvan J, Sochor J, Tanhauserova V, Raudenska M, Krizkova S, Adam V, Eckschlager T, Kizek R, Masarik M.

Oncol Rep. 2012 Sep;28(3):806-14. doi: 10.3892/or.2012.1897. Epub 2012 Jul 3.

PMID:
22766626
9.

Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.

Sun R, Fu X, Li Y, Xie Y, Mao Y.

BMC Genomics. 2009 Feb 26;10:93. doi: 10.1186/1471-2164-10-93.

10.

Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P.

Mol Cancer. 2008 Jan 21;7:7. doi: 10.1186/1476-4598-7-7.

11.

In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.

Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS.

Cancer. 1996 May 1;77(9):1862-72.

12.
13.

Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues.

Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H.

Cancer Lett. 2003 Oct 28;200(2):187-95.

PMID:
14568174
14.

miRNAs differentially expressed in prostate cancer cell lines after soy treatment.

Rabiau N, Trraf HK, Adjakly M, Bosviel R, Guy L, Fontana L, Bignon YJ, Bernard-Gallon DJ.

In Vivo. 2011 Nov-Dec;25(6):917-21.

PMID:
22021684
15.

MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.

Zheng C, Yinghao S, Li J.

Med Oncol. 2012 Jun;29(2):815-22. doi: 10.1007/s12032-011-9934-8. Epub 2011 Apr 13.

PMID:
21487968
16.

The microRNA profile of prostate carcinoma obtained by deep sequencing.

Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F.

Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30.

17.

MicroRNA expression profiling in prostate cancer.

Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T.

Cancer Res. 2007 Jul 1;67(13):6130-5.

18.

hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.

Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC.

Mol Cancer. 2005 Sep 9;4:32.

19.

Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells.

Hessvik NP, Phuyal S, Brech A, Sandvig K, Llorente A.

Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1154-63. doi: 10.1016/j.bbagrm.2012.08.016. Epub 2012 Sep 8.

PMID:
22982408
20.

Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.

Xu J, Li CX, Lv JY, Li YS, Xiao Y, Shao TT, Huo X, Li X, Zou Y, Han QL, Li X, Wang LH, Ren H.

Mol Cancer Ther. 2011 Oct;10(10):1857-66. doi: 10.1158/1535-7163.MCT-11-0055. Epub 2011 Jul 18.

Items per page

Supplemental Content

Write to the Help Desk